What did @welldone.tx actually say?
The creator walked viewers through using an online peptide dosage calculator to figure out injection volumes for what they called "the peppy" — almost certainly a growth hormone secretagogue like ipamorelin or CJC-1295, given the 250 microgram starting dose and the vague branding. They described reconstituting a 15 mg vial with 3 mL of bacteriostatic water, landing on a draw of 5 units on a 0.3 mL insulin syringe to hit 250 mcg per dose. They also flagged that if they "don't feel it" within a few days, they plan to raise the dose and question their source's quality.
Credit where it's due: the reconstitution math they walked through is technically correct for the values they entered. Five units on a 100-unit insulin syringe with those concentrations does land at approximately 250 mcg. That part checks out.
Does the science back this up?
The dosage calculator approach is not wrong, but it is doing a lot of heavy lifting for a process that actually requires clinical oversight. The peptide they appear to be using — a GHRH/GHRP combination or similar secretagogue — has no FDA-approved indication and very limited human trial data.
Most of what we know about ipamorelin and CJC-1295 comes from small pharmacokinetic studies. A 2008 study by Raun et al. in the European Journal of Endocrinology characterized ipamorelin's GH-releasing profile in animals, and early human data exists, but large-scale randomized controlled trials in healthy adults for "optimization" simply do not exist. The assumption that "feeling something" within two to three days is a reliable efficacy signal has no clinical basis. Growth hormone axis peptides can take weeks to show measurable IGF-1 changes, and subjective feelings are notoriously poor proxies for actual hormonal effect.
What did they get wrong (or right)?
They got the math right. That is genuinely the floor, not the ceiling, of what someone should know before self-injecting a peptide.
What they got wrong is more consequential. The idea that "not feeling it in three days" means you should raise your dose is a pattern that leads to compounding errors, not better outcomes. Dose titration for peptides is not driven by subjective sensation timelines. It is driven by bloodwork, specifically IGF-1 levels, and clinical assessment.
Saying the source might "not be a reputable source" if the peptide doesn't work is also backwards reasoning. Peptide quality matters enormously — unregulated research chemicals vary wildly in purity and concentration — but "not feeling results" is not a reliable way to detect an underdosed or contaminated vial. That requires third-party certificate of analysis review before you ever reconstitute anything.
- Correct: Reconstitution math using the calculator values they described
- Correct: Noting the microgram/milligram conversion confuses people
- Incorrect: Using subjective feeling as a three-day efficacy signal
- Incorrect: Self-escalating dose without bloodwork or clinical guidance
- Unverifiable: The source recommendation and affiliate code
What should you actually know?
Peptide reconstitution math matters, but it is one small piece of a process that carries real risk when done outside medical supervision. Injection site infections, immune reactions, and hormonal dysregulation are documented risks — not theoretical ones.
The FDA has not approved any of the peptides commonly called "research chemicals" for human use in this context. Compounded peptides from telehealth providers operate under specific regulatory frameworks that require a valid patient-provider relationship and individualized prescribing. Buying peptides from a vendor because someone online "came highly recommended" and posting an affiliate code does not meet that standard.
If you are interested in peptide therapy, the pathway is a licensed provider, baseline labs including IGF-1 and a metabolic panel, and follow-up bloodwork to assess response. Dose changes should be provider-directed, not based on whether you "feel peppy" by day three.
The bottom line
This video is a good illustration of the gap between knowing how to draw up a syringe and knowing whether you should. The creator is clearly trying to be helpful, and the calculator walkthrough is more accurate than most peptide content floating around TikTok. But the framing — self-sourced, affiliate-linked, dose-escalate-by-feel — is exactly the kind of approach that turns a low-risk compound into a higher-risk situation. The math was fine. The clinical reasoning needs work.